These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 9687844)

  • 61. [Hepatitis B vaccination in France: vaccination coverage in 2002].
    Denis F
    Bull Acad Natl Med; 2004; 188(1):115-23. PubMed ID: 15368931
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Strengthen hepatitis B vaccination in populations other than newborn babies].
    Zhuang H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 May; 25(5):376. PubMed ID: 15231153
    [No Abstract]   [Full Text] [Related]  

  • 63. Report of the Hepatitis B Working Group.
    Can Commun Dis Rep; 1994 Jul; 20(13):105-12. PubMed ID: 7920361
    [No Abstract]   [Full Text] [Related]  

  • 64. Hepatitis B vaccination: myths and controversies.
    Mittal SK
    Indian J Pediatr; 2003 Jun; 70(6):499-502. PubMed ID: 12921320
    [TBL] [Abstract][Full Text] [Related]  

  • 65. From the Centers for Disease Control and Prevention. Update: recommendations to prevent hepatitis B virus transmission--United States.
    JAMA; 1999 Mar; 281(9):790. PubMed ID: 10070986
    [No Abstract]   [Full Text] [Related]  

  • 66. An economic evaluation of universal vaccination against hepatitis B virus.
    Fenn P; Gray A; McGuire A
    J Infect; 1996 May; 32(3):197-204. PubMed ID: 8793708
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Private immunisation--the agony is worse than the injection.
    Rainier-Pope CR
    S Afr Med J; 1997 Jul; 87(7):914. PubMed ID: 9259742
    [No Abstract]   [Full Text] [Related]  

  • 68. Economic evaluation of vaccination programmes: a consensus statement focusing on viral hepatitis.
    Beutels P; Edmunds WJ; Antoñanzas F; De Wit GA; Evans D; Feilden R; Fendrick AM; Ginsberg GM; Glick HA; Mast E; Péchevis M; Van Doorslaer EK; van Hout BA;
    Pharmacoeconomics; 2002; 20(1):1-7. PubMed ID: 11817988
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Vaccine uptake rather than disease mitigation seems to be aim of universal hepatitis B vaccination in the UK.
    Puliyel J
    BMJ; 2013 Sep; 347():f5187. PubMed ID: 24004990
    [No Abstract]   [Full Text] [Related]  

  • 70. Universal hepatitis B vaccination.
    Kretzschmar M; de Wit A
    Lancet Infect Dis; 2008 Feb; 8(2):85-7; author reply 90. PubMed ID: 18222156
    [No Abstract]   [Full Text] [Related]  

  • 71. 2-dose hepatitis vaccination versus 3-dose regimen.
    Meyerhoff AS; Greenberg DP
    Pediatrics; 2002 Jun; 109(6):1183-4; author reply 1183-4. PubMed ID: 12042564
    [No Abstract]   [Full Text] [Related]  

  • 72. Thirty-year outcomes of the national hepatitis B immunization program in Taiwan.
    Chiang CJ; Yang YW; You SL; Lai MS; Chen CJ
    JAMA; 2013 Sep; 310(9):974-6. PubMed ID: 24002285
    [No Abstract]   [Full Text] [Related]  

  • 73. Hepatitis B vaccination and adolescents: A lost generation.
    Stahl JP; Denis F; Gaudelus J; Cohen R; Lepetit H; Martinot A
    Med Mal Infect; 2016 Feb; 46(1):1-3. PubMed ID: 26746325
    [No Abstract]   [Full Text] [Related]  

  • 74. [Strategy for the use of hepatitis B vaccine in the United Kingdom, France and Italy].
    Stroffolini T
    Ann Ist Super Sanita; 1984; 20(2-3):201-4. PubMed ID: 6242513
    [No Abstract]   [Full Text] [Related]  

  • 75. The Viral Hepatitis Prevention Board and earlier efforts at hepatitis B control.
    Wilde H
    Vaccine; 1996 Jun; 14(8):837-8. PubMed ID: 8817832
    [No Abstract]   [Full Text] [Related]  

  • 76. [Practical recommendations for general introduction of hepatitis B vaccination].
    Vaudaux B; Wimmersberger A
    Soz Praventivmed; 1998; 43 Suppl 1():S69-71, S143-5. PubMed ID: 9833271
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Hepatitis B vaccination: knowledge and acceptance by Swiss physicians].
    Gugelmann RJ; Freed GL; Desgrandchamps D; Diebold P
    Soz Praventivmed; 1998; 43 Suppl 1():S57-60, S130-3. PubMed ID: 9833268
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Assessment of hepatitis B vaccine coverage by using the national immunization day in Chandigarh.
    Bhatia V; Swami HM
    Indian J Med Sci; 2000 Aug; 54(8):347-9. PubMed ID: 11143750
    [No Abstract]   [Full Text] [Related]  

  • 79. Cost-benefit analysis of the Polish hepatitis B prevention programme.
    Wiewióra-Pilecka D
    Vaccine; 2000 Feb; 18 Suppl 1():S52-4. PubMed ID: 10683548
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Reply to Editorial on "What is a potentially damaging vaccination delay in children younger than 2 years?".
    Dubos F; Gras P; Martinot A
    Hum Vaccin Immunother; 2016 Aug; 12(8):2057-2058. PubMed ID: 27294499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.